Insight on AV-45 binding in white and grey matter from histogram analysis: a study on early Alzheimer’s disease patients and healthy subjects
- 489 Downloads
AV-45 amyloid biomarker is known to show uptake in white matter in patients with Alzheimer’s disease (AD), but also in the healthy population. This binding, thought to be of a non-specific lipophilic nature, has not yet been investigated. The aim of this study was to determine the differential pattern of AV-45 binding in white matter in healthy and pathological populations.
We recruited 24 patients presenting with AD at an early stage and 17 matched, healthy subjects. We used an optimized positron emission tomography-magnetic resonance imaging (PET-MRI) registration method and an approach based on an intensity histogram using several indices. We compared the results of the intensity histogram analyses with a more canonical approach based on target-to-cerebellum Standard Uptake Value (SUVr) in white and grey matter using MANOVA and discriminant analyses. A cluster analysis on white and grey matter histograms was also performed.
White matter histogram analysis revealed significant differences between AD and healthy subjects, which were not revealed by SUVr analysis. However, white matter histograms were not decisive to discriminate groups, and indices based on grey matter only showed better discriminative power than SUVr. The cluster analysis divided our sample into two clusters, showing different uptakes in grey, but also in white matter.
These results demonstrate that AV-45 binding in white matter conveys subtle information not detectable using the SUVr approach. Although it is not more efficient than standard SUVr in discriminating AD patients from healthy subjects, this information could reveal white matter modifications.
KeywordsAV-45 Amyloid Intensity histogram Discrimination analysis Alzheimer’s disease
This study was supported by a grant from the University Hospital of Toulouse, local grant 2007, and a grant from the Agence Nationale de la Recherche. The authors thank the promoter of this study and Toulouse University Hospital.
Conflict of interest
The authors declare that they have no conflict of interest.
- 7.Saint-Aubert L et al. Cortical florbetapir-PET amyloid load in prodromal Alzheimer’s disease patients. Eur J Nucl Med Mol Imaging. 2013;3(1):43.Google Scholar
- 21.Conover WJ, Iman RL. Rank transformations as a bridge between parametric and nonparametric statistics—rejoinder. Am Stat. 1981;35(3):132–3.Google Scholar
- 29.Hong YT, et al. Amyloid imaging with carbon 11-labeled Pittsburgh compound B for traumatic brain injury. JAMA Neurol. 2014;71(1):23–31.Google Scholar
- 30.Gurol ME, et al. Cerebral amyloid angiopathy burden associated with leukoaraiosis: A positron emission tomography/magnetic resonance imaging study. Ann Neurol. 2013;73(4):529–536.Google Scholar